TDO2 and leukemia: The results indicated that KYN significantly increased cell proliferation marker expression (cyclin D1, E2F1, and Ki-67), as well as IDO1, TDO2, Ikaros1, AML1, and ETV6 expression, in leukemia cells (Fig. 5A).